INDUSTRY: Healthcare and Pharmaceuticals

Access and Affordability

For healthcare and pharmaceutical organisations, access and affordability are pillars of long-term sustainability, intertwined with ethical responsibility and market success. Ensuring equal access to essential medicines prevents the spread of preventable diseases and reduces future healthcare costs. Sustainable pricing models that consider both innovation and public well-being are crucial for long-term financial stability and positive societal impact. Addressing affordability, particularly through targeted programs for vulnerable populations, not only fosters healthier communities but also builds lasting loyalty and brand reputation.

Customer safety and product quality

Customer safety and product quality are integral to sustainability in healthcare and pharmaceuticals, protecting public health and trust while safeguarding industry legitimacy. Counterfeit drugs jeopardise both lives and market stability. Organisations must prioritise robust anti-counterfeiting measures throughout the supply chain, embracing technological solutions like serialisation and secure packaging. Additionally, the responsible management of controlled substances is crucial. Tight controls and transparent reporting, alongside patient education programs, prevent diversion and abuse, building trust with patients and regulators. Find out more about our supply chain audit tool, FutureConnect.

Business ethics

While posing significant challenges to food and beverage brands, packaging is a core sustainability issue for consumers. Producers, distributors, retailers and restaurants face a growing imperative to optimise packaging for both environmental and market considerations. Sustainable packaging choices that minimise material usage, prioritise recyclability, and reduce waste not only align with consumer values but also unlock significant business advantages. Optimised packaging can contribute to brand differentiation, drive operational efficiencies, and even open doors to new, environmentally conscious markets. From adopting lightweight bioplastics to exploring innovative reuse systems, the industry has a wealth of opportunities to rewrite its environmental narrative.

Waste Management

Healthcare and pharmaceutical organisations grapple with a colossal waste problem, posing both environmental and financial burdens. The volumes of waste produced by a hospital, for example, can be staggering, equating to many hundreds of thousands of tonnes annually. Infectious waste, pharmaceuticals, and chemical residues require specialised treatment and disposal, significantly driving up costs, posing a safety hazard to workers and contaminating the environment. 

Despite the challenges, implementing waste reduction initiatives, exploring alternative disposal methods, and collaborating with waste management companies can significantly reduce costs and environmental impact. 

 Employee wellbeing and inclusion

Burnt-out, disengaged employees translate to compromised patient care, higher turnover costs, and a tarnished reputation. Prioritising employee wellbeing with robust mental health support, flexible work arrangements, and opportunities for growth fosters a positive, productive environment that attracts and retains top talent. Inclusion amplifies this impact, drawing from diverse perspectives to improve innovation, decision-making, and understanding of patient needs. 

Energy efficiency

For larger healthcare and pharmaceutical companies in particular, energy efficiency offers a crucial step towards streamlining operational costs and minimising environmental impact. Cutting energy costs through the use of LED lighting, smart building controls and energy-efficient equipment can slash energy budgets as well as drastically reducing greenhouse gas emissions.

BOOK A DISCOVERY CALL